Olmesartan Medoxomil/Hct Teva (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil/Hct Teva, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is prescribed for adults. GNH USA supplies Olmesartan Medoxil/Hct Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxil/Hct Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan Medoxil/Hct Teva is used primarily for blood‑pressure management through the renin‑angiotensin system. - Hypertension: low‑to‑moderate blood‑pressure reduction, helping achieve target BP goals. - Heart failure: supports fluid balance when combined with a diuretic, reducing cardiac workload. - Diabetic nephropathy protective effect in hypertensive patients: slows progression of kidney damage. - Post‑cardiac surgery care in selected patients: assists in maintaining stable hemodynamics. -   a

Common Side Effects: - Headache  de 

t 

Precautions: -  t 

Interactions